Establishment and characterization of novel highly aggressive HER2‑positive and triple‑negative breast cancer cell lines-Reference-Cited by-同舟云学术

Establishment and characterization of novel highly aggressive HER2‑positive and triple‑negative breast cancer cell lines

Published:2021-10-15 Issue:6 Volume:46 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Thongchot Suyanee¹,Jamjuntra Pranisa¹,Prasopsiri Jaturawitt¹,Thuwajit Peti¹,Sawasdee Nunghathai²,Poungvarin Naravat³,Warnnissorn Malee⁴,Sa‑Nguanraksa Doonyapat⁵,O‑Charoenrat Pornchai⁶,Yenchitsomanus Pa-Thai²,Thuwajit Chanitra¹

Affiliation:

1. Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

2. Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

3. Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

4. Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

5. Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

6. Breast Center, Medpark Hospital, Bangkok 10110, Thailand

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy in Combination with Chemotherapy for Triple-negative Breast Cancer;Mini-Reviews in Medicinal Chemistry;2024-03

2. Stimulating T cell responses against patient-derived breast cancer cells with neoantigen peptide-loaded peripheral blood mononuclear cells;Cancer Immunology, Immunotherapy;2024-02-13

3. Current understanding of adenoid cystic carcinoma in the gene expression and targeted therapy;Holistic Integrative Oncology;2023-04-12

4. Novel CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosis;Human Cell;2022-12-02